IMPROVED MAGNETICALLY REACTIVE VESICULAR BODIES
20190117571 · 2019-04-25
Assignee
Inventors
Cpc classification
A61K9/5094
HUMAN NECESSITIES
A61K9/127
HUMAN NECESSITIES
A61K9/1271
HUMAN NECESSITIES
A61K41/0028
HUMAN NECESSITIES
International classification
A61K9/127
HUMAN NECESSITIES
Abstract
A method of preparing a vesicular particle having at least in part a lipid and/or polymeric membrane that is a barrier between the interior and exterior of the vesicular particle, wherein the membrane includes at least one inorganic core nanoparticle embedded in the membrane, the method includes the steps of i) providing a first dispersion with one or more inorganic core particles having a hydrophobic dispersant shell, in a solution of membrane forming lipids and/or polymers in a non-aqueous solvent; and ii) introducing the first dispersion into a non-solvent for the membrane forming lipids and/or polymers, wherein the volume of the non-solvent exceeds the volume of the first dispersion, thereby forming the vesicular particles; the produced particle preparations and their uses.
Claims
1. A method of preparing a vesicular particle having at least in part a lipid and/or polymeric membrane that is a barrier between the interior and exterior of said vesicular particle, wherein said membrane comprises at least one magnetic nanoparticle embedded in said membrane, said method comprises the steps of: i) providing a first dispersion with one or more inorganic core particles having a hydrophobic dispersant shell in a solution of membrane forming lipids and/or polymers in a non-aqueous solvent; and ii) introducing the first dispersion into a fluid that is a non-solvent for the membrane forming lipids and/or polymers, wherein the volume of the non-solvent exceeds the volume of the first dispersion and the non-aqueous solvent and the non-solvent are miscible, thereby forming the vesicular particles.
2. The method of claim 1, wherein said non-aqueous solvent comprises tetrahydrofuran.
3. The method of claim 1, wherein the introducing step ii) is turbulent, preferably by stirring, shaking or sonication of the non-solvent or by injection or dripping of the non-aqueous solvent into the non-solvent, and/or wherein the introducing step ii) is under agitation so that vesicles with an average diameter of 20 nm to 400 nm form, preferably vesicles with an average diameter of 30 nm to 200 nm, especially preferred 35 nm to 100 nm, form.
4. The method of claim 1, wherein in step ii) the introduced volume of the non-aqueous solvent is less than half of the volume of the non-solvent.
5. The method of claim 1, wherein the inorganic core particles are of an average size between 1 nm to 15 nm in diameter.
6. The method of claim 1, wherein step i) is providing a first dispersion with one or more inorganic core particles having a hydrophobic dispersant shell in a solution of membrane forming lipids in a non-aqueous solvent, preferably wherein the lipids comprise a fatty acid ester group selected from palmitoyl-, lauryl-, myristoyl-, oleoyl-, stearoyl-groups and/or wherein at least one of the lipids has a melting transition above 38 C.
7. The method of claim 1, comprising the steps of: i) providing a first dispersion with one or more inorganic core particles having a hydrophobic dispersant shell and an inorganic paramagnetic or superparamagnetic core of between 1 to 15 nm in diameter, in a solution of membrane forming lipids in tetrahydrofuran; and ii) mixing the first dispersion into an aqueous fluid under rapid conditions and/or with agitation, thereby forming the vesicular particles.
8. The method of claim 1, wherein the inorganic core particles comprise dispersant molecules bound to the particle surface, that (a) are at an average density of at least 1.1, preferably at least 3.0, dispersant molecules per nm.sup.2 of the inorganic core surface, and/or (b) form a shell of constant dispersant density and a further shell of gradually reduced dispersant density with increasing distance from the inorganic core surface.
9. The method of claim 1, further comprising sonicating the vesicular particles of step ii).
10. The method of claim 1, comprising adding an amphiphilic polymer to the solution of step i) or to the forming vesicular particles of step ii).
11. The method of claim 10, wherein said amphiphilic polymer comprises a hydrophilic block of 20-60% v/v.
12. A composition of a plurality of vesicular particles each having at least in part a lipid and/or polymeric membrane that is a barrier between the interior and exterior of said vesicular particle, wherein said membrane comprises inorganic core nanoparticles embedded in said membrane, said composition comprising: A) said embedded nanoparticles are in a concentration of at least 0.5% (w/w per lipid and/or polymer), and wherein said concentration is constant or decreases by less than 25% (percentage of w/w concentration) at least during 24 hours at standard conditions in an aqueous dispersion with physiological buffer; and/or B) said vesicular particles are formed by a method of any one of claims 1 to 11.
13. The composition of claim 12, wherein the inorganic core nanoparticles comprise a magnetic core, preferably a superparamagnetic core of between 1 to 15 nm in diameter, and a hydrophobic dispersant shell.
14. The composition of claim 12, wherein a pharmaceutical agent is contained in the lumen or in the membrane of the vesicular particles.
15. Use of the composition of claim 12 for administration to a subject or to a cell or tissue culture, preferably wherein the composition is administered to a subject and said subject is irradiated so that the inorganic core nanoparticles are excited and/or heated.
Description
FIGURES
[0088]
[0089]
[0090]
[0091]
[0092]
[0093]
[0094]
[0095]
[0096]
[0097]
[0098]
[0099]
[0100]
[0101]
[0102]
[0103]
[0104]
[0105]
[0106]
[0107]
[0108]
[0109]
[0110]
[0111]
[0112]
[0113]
[0114]
[0115]
[0116]
[0117]
[0118]
[0119]
[0120]
[0121]
[0122]
[0123] ), 4 wt % (
) 6 wt % (
), 8 wt % (
) 10 wt % (
) SPION after formation. (
) shows the size distribution of magnetoliposomes with 4 wt % SPION 11 months after their formation.
[0124]
[0125]
[0126]
EXAMPLES
Example 1: General Material and Methods
[0127] Reagents
[0128] All reagents were purchased from Sigma Aldrich and used as received without further purification.
[0129] Ultrapure water (Millipore USA, R=18 Mcm); THF (Chromasolv plus for HPLC, inhibitor free) 99%; 1,4-Dioxane (anhydrous) 99.8%; EtOAc (anhydrous) 99.8%; DMF (ACS reagent) 99.8%; EtOH (Chromasolv for HPLC, absolute) 99.8%; PBS tablets (0.01 M phosphate buffer, 0.0027 M potassium chloride and 0.137 M sodium chloride, pH 7.4, at 25 C.); TBS BioUltra tablets (0.05 M TRIS-HCl buffer; 0.15 M sodium chloride; pH 7.6 at 25 C.)
[0130] All employed P-NDA-coated magnetite nanoparticles originated from the same batches.
[0131] All lipids were obtained dissolved in Chloroform from Avanti Lipids Inc. and high-vacuum dried for at least 24 h before further use.
[0132] 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) >99%, 1-myristoyl-2-palmitoyl-sn-glycero-3-phosphocholine (DMPC) >99%, 1-myristoyl-2-palmitoyl-sn-glycero-3-phosphocholine (MPPC) >99%, 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) >99%. Where nothing else is stated, POPC was used as lipid.
[0133] For polymersomes:
[0134] 4-Cyano-4-(phenylcarbonothioylthio)pentanoic acid >97%; Isoprene 99% (contains <1000 ppm p-tert-butylcatechol as inhibitor); N-Isopropylacrylamide 97%; 2,2-Azobis(2-methylpropionitrile) 98%; S-Methyl methanethiosulfonate 97%; N,N-Dimethylethylenediamine 95%; 5-(Dimethylamino)naphthalene-1-sulfonyl chloride BioReagent, powder and chunks 99% (HPLC); Ethanolamine ACS reagent 99.0%; N,N-Dicyclohexylcarbodiimide puriss 99.0% (GC); 4-(Dimethylamino)pyridine ReagentPlus 99%; Milli-Q water (R=18 Mcm); Methanol anhydrous 99.8%; Acetone Chromasolv for HPLC 99.9%; Dichloromethane anhydrous 99.8% (contains 50-150 ppm amylene as stabilizer); Chloroform 99.5% (containing 100-200 ppm amylenes as stabilizer); Tetrahydrofuran Chromasolv Plus for HPLC 99.9% (inhibitor-free); 1,4-Dioxane ACS reagent 99.0%; Toluene anhydrous 99.8%; n-Hexane anhydrous 95%; Aluminium oxide activated, basic, Brockmann I (150 mesh); (+)-D-Trehalose dihydrate from corn starch >99%. N-isopropylacrylamide (NIPAM) was recrystallized from hexane/toluene:1/1 v/v. 2,2-Azobis(2-methylpropionitrile) (AIBN) was recrystallized from methanol. Isoprene was purified by passing through a column of basic alumina.
[0135] Measurement Conditions
[0136] TEM and Analysis:
[0137] TEM studies were performed on a FEI Tecnai G2 20 transmission electron microscope operating at 120 kV or 200 kV for high resolution imaging. Samples were prepared by dropcasting aqueous vesicle dispersions onto 300-mesh carbon-coated copper grids. Size distributions were evaluated using PEBBELS.
[0138] Dynamic Light Scattering:
[0139] Hydrodynamic size distributions were measured on a Malvern Zetasizer Nano-ZS (Malvern UK) in Milli-Q water or buffer at 25 C. in 173 backscattering mode. Samples were equilibrated for 120 s each and the autocorrelation function was obtained by averaging 3 runs. Samples were measured as-prepared without further dilution.
[0140] OD Measurements:
[0141] UV-Vis spectra were collected at a scan speed of 400 nm/min on a Hitachi UV-2900 spectrophotometer referenced against pure solvent.
[0142] TGA/DSC Measurements:
[0143] Thermograms were recorded on a Mettler-Toledo TGA/DSC 1 STAR System in the temperature range 25-650 C. with a ramp of 10K/min in synthetic air (O.sub.2). 70 l aluminum oxide crucibles were filled with 0.5-2 mg sample and the rest mass was evaluated at 500 C. The mass loss was obtained by placing horizontal steps to the TGA curves.
[0144] ATR-FTIR Measurements:
[0145] Mid-IR powder spectra of the lyophilized samples were collected on a single reflection Bruker Platinum Diamond ATR at a resolution of 4 cm.sup.1 by averaging 32 scans.
[0146] .sup.1H-NMR Measurements:
[0147] .sup.1H-solution spectra were collected on a Bruker DPX operating at 300 MHz in D2O using 1 mg 4,4-dimethyl-4-silapentane-1-sulfonic acid (DSS) as an internal standard.
[0148] Sample Preparation
[0149] Trehalose Fixation:
[0150] An aliquot of 10% w/v trehalose stock solution was added to the vesicle suspension to give a final trehalose concentration of 1-2% w/v. The sample was gently vortexted for 1 min before a drop of the sugar-vesicle solution was placed onto a carbon-coated copper grid. The vesicles were allowed to adsorb for 30 min before the grid was cautiously washed with a drop of Milli-Q water. Samples were dried for several hours in air before examined in TEM.
[0151] Freeze-Fracture/-Etching:
[0152] 5 l vesicle suspension was loaded onto a gold specimen holder and shock-frozen by quickly immersing it into dichlorofluoromethane (Freon R22) at 196 C. The fixed sample was mounted onto a sample holder under cryogenic temperatures and transferred to a Balzer BAF400 freeze-etching system. After an initial equilibration period of 10 min at 150 C., the sample was slowly warmed to 100 C. for fracturing. The sample top was stripped off with a N2(l)-cooled microtome and the exposed surface etched by sublimation of 40 nm ice in high-vacuum (90 sec at 100 C. and 10.sup.6 mbar). A 2 nm Pt-shadowing was evaporated from a 45 angle followed by a carbon support layer of 20 nm. The sample was subsequently warmed to room-temperature and cleaned in 70% H2SO4 overnight to digest all organic material. The cleaning medium was exchanged five times for Milli-Q water, the washed replicas loaded onto 300 mesh copper grids and dried overnight before imaged in TEM.
[0153] NMR Determination of Residual Solvent:
[0154] Vesicles were prepared by the standard 1:10 solvent inversion procedure to 0.5 mg/ml POPC in 10 ml D.sub.2O containing 1 mg/ml DSS and withdrawing 1 ml aliquots right after THF addition and after 24 h of evaporation. The size of the formed liposomes was determined to be around 200 nm.
[0155] Vesicle Preparation by Rehydration Plus Extrusion:
[0156] 5 mg POPC mixed with 5% w/w SPIONs in 3 ml CHCl.sub.3 were dried on the rotary evaporator and lyophilized in high vacuum for 12 h. The dry lipid-nanoparticle film was rehydrated in 1 ml Milli-Q water for 2 h at 50 C. and detached from the flask wall by gentle sonication (330 sec). The rehydrated sample was subsequently extruded 31 times through 100 nm track-etched polycarbonate (PC) membranes (Avanti Lipids) or PVP-coated PC membranes (Whatman).
[0157] Magnetic Column Separation:
[0158] A perforated Eppendorf tube was packed with 0.5 g of ultrafine steel wool and flushed thrice with ultrapure water. The column was attached to a 1 T Nd/Fe/B-magnet and the sample of SPION-loaded lipid vesicles/aggregates was passed through the column. UV/VIS quantification after up-concentration to the initial volume (speed-vac) was used to access the amount of aggregates formed.
Example 2: SPION Preparation
[0159] Monodisperse 3.5 nm N-palmityl-6-nitrodopamide (P-NDA) capped superparamagnetic iron oxide nanoparticles (SPIONs) were synthesized as reported previously (PCT/EP2015/068253 (WO2016/020524) or Bixner et al., Langmuir, 2015, 31, 9198-9204). In brief, 200 mg as-synthesized SPIONs were purified by repeated pre-extraction in hot MeOH containing 1 mM oleic acid as stabilizer before exchanged in a mixture of 150 mg P-NDA in DMF:CHCl.sub.3:MeOH=6:3:1 for 3 h under nitrogen gas. Newly capped SPIONs were evaporated to the DMF fraction, precipitated by adding excess MeOH and collected via magnetic decantation. The particles were purified by threefold extraction in hot MeOH. Mixed dispersant SPIONs were post-coated with 100 mg P-NDA in minimal 2,6-lutidine for 48 h at 50 C. under inert atmosphere, evaporated to dryness and purified by hot MeOH extractions. SPIONs were lyophilized from THF:H.sub.2O (5:1).
Example 3: Vesicle Preparation by Solvent Inversion
[0160] The respective amount of high-vacuum dried lipid (usually 5 mg) or respective nanoparticle-lipid mixes were dissolved in 1 ml anhydrous THF and dropwise (approx. 1 drop per second) added into 10 ml aqueous phase (ultrapure water or buffers) under constant magnetic stirring (400 rpm). THF was evaporated for 24 h under air circulation or N.sub.2 flow. The vesicle suspension was refilled with water or buffer to the original concentration. Where nothing else is specifically stated 1-palmityl-2-oleoyl-sn-glycero-phosphatidyl choline (POPC) was used as lipid.
Example 4: Calculations
[0161] M.sub.w calculation of core-shell SPIONs (d=3.5 nm)
m.sub.core-shell=m.sub.core+m.sub.shell
M.sub.w calculation of liposomes (d=100 nm)
estimation of maximum SPION loading per liposome (d=100 nm)
The calculated % w/w refers to weight-% SPION per lipid to ensure easy comparability to the SPION input values given in the main manuscript.
Example 5: Vesicle Formation and Lamellarity
[0162] It is most important to assemble large (100 nm in diameter), monodiperse and unilamellar vesicles to optimize loading and control rapid triggered release. Large unilamellar vesicles composed of 1-palmityl-2-oleoyl-sn-glycero-phosphatidyl choline (POPC) were prepared using solvent inversion. The non-polar, water miscible solvent THF was used as carrier/transfer fluid for the mix of monodisperse N-palmityl-6-nitrodopamide (P-NDA) coated magnetite particles and lipids; the mix is rapidly diluted upon injection into a larger volume of aqueous phase. During the assembly process THF is thought to behave as a co-solvent scaffold for both species followed by progressive dialysis. In this sense THF serves as a fluidizer that provides the system with a combination of solvation and flexibility to rearrange while being slowly forced into the final assembly. THF itself is a high vapor pressure solvent and is readily evaporated under continuous nitrogen flow until a homogeneous suspension of lipid vesicles containing SPIONs is achieved. An efficient removal of solvents is especially important with respect to delivery applications as remnants render liposomes leaky and might induce toxicity. The amount of residual THF in the preparations was quantified by NMR to be 0.05% or 50 ppm of its initial value (see
[0163] Attempts to replace THF by other commonly used organic solvents or solvent mixtures like 1,4-dioxane, EtOAc/EtOH or DMF, resulted in weaker structure of magnetoliposomes and/or reduced nanoparticle dispersion.
[0164]
[0165] The size distribution, morphology and lamellarity of the liposomes were additionally checked by freeze-fracture/-etching TEM and by trehalose fixation of the preparations (
Example 6: Magnetosome Formation in Various Media
[0166] Two common buffer systems were tested: 1PBS (140 mM NaCl, 10 mM Na.sub.2HPO.sub.4, pH=7.4) and 1TBS (140 mM NaCl, 10 mM Tris, pH=7.4). PBS is commonly used to mimic intracellular fluids but is particularly incompatible with surface modified iron oxide nanoparticles since phosphate ions can displace dispersants from the particle surface and reduce colloidal stability. TBS is in this respect less challenging but has the same ionic strength. Typical preparations of SPION-loaded vesicles (0.5 mg/ml POPC; 1:10 inversion; w/wo 5% w/w SPION;) exhibited monomodal size-distributions with a scattering maximum slightly above 100 nm in both buffers. Slightly larger average hydrodynamic diameters and broader distributions were observed in PBS than in TBS (see
Example 7: Dependence of Vesicle Formation on Lipid Species and Temperature
[0167] While unsaturated lipids easily assembled into the desired LUVs through solvent inversion from THF in water, formation of saturated lipid vesicles was highly dependent on the chain length of the employed lipid. Saturated lipids such as DMPC, MPPC or DPPC were insoluble in THF at room-temperature and required gentle heating in order to be dissolved prior to inversion into aqueous medium. Saturated lipid samples were assembles by dropwise addition of the warm THF solutions (around T.sub.m of the lipid species) into the stirred, equilibrated aqueous phases immersed in a thermostated water bath (T=T.sub.m10 C.)
[0168] For 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC; T.sub.m=24 C.), exhibiting the shortest symmetric acyl chain length that was tested and therefore the lowest melting temperature, no marked differences in size distribution were observed for preparations below (water-bath, 15 C.) or above the T.sub.m (37 C.). All preparations yielded stable vesicles with rather broad distributions (PDI=0.36-0.48) centered around 89 nm (
[0169] A slightly different behavior was observed for lipids with unsymmetric acyl chain lengths. 1-myristoyl-2-palmitoyl-sn-glycero-3-phosphocholine (MPPC; T.sub.m=35 C.) preparations formed at T>T.sub.m resulted in size distributions at slightly larger diameters than at T<T.sub.m (
[0170] While the as-prepared DMPC and MPPC assemblies generally were sub-micron sized and stable for a few weeks, DPPC assemblies were distributed over a wide size range and colloidally unstable. For the latter, precipitation of excess SPIONs occurred during evaporation of the organic solvent accompanied by a significant increase in turbidity of the solutions. Storage at room-temperature led to the formation of flakes and precipitation of the sample (
[0171] The difference in formation behavior among saturated and unsaturated lipids can be due to solvent influence on lipid interdigitation. It is generally accepted that a chemical inducer such as organic solvent adsorbs to the interfacial region of the lipid where it causes an increase of the head-group volume of the amphiphile. This in turn alters the head-group tilt causing the formation of unfavorable voids to lamellar phases, which rearrange to a more stable interdigitated structure in which the lipids adopt a transverse stacked, alternating monolayer pattern. The latter is stabilized by organic solvent capping of the terminal methyl groups which face the aqueous bulk and persist until a lower critical solvent concentration is reached upon which interdigited structures coalesce into large, vesicular arrangements. Saturated phospholipids are prone to interdigitation fusion in aqueous solvent mixtures, notably THF-H.sub.2O, whereas unsaturated lipids are strongly disfavored to interdigitate by virtue of their molecular geometry and lower phase transition temperatures.
[0172] Insensitivity of vesicle quality to temperature is surprising since the lipid phase state is known to have significant influence on interdigitation. Generally the liquid crystalline state, which the lipids are in due to dissolution in THF around their T.sub.m, is highly unfavorable for interdigitation, because disordered acyl chains are more accessible to water. However the steric effect of solvent adsorption to the interface was reported to dominated at room temperature which also seems to hold in our case.
[0173] The much lower dispersity achieved for long-chain phosphocholine-lipid assemblies seems to correlate with their overall lower solubility in THF. Quick dilution upon injection triggers rapid loss of co-solvency causing large interdigitated assemblies to be formed for which the rate of fusion is accelerated because reduced curvature provides less steric hindrance to glide fusion of opposing monolayers.
[0174] Magnetosomes with high T.sub.m and therefore composed of saturated lipids with long fatty acid chains are, however, required for in vivo applications exploiting the difference between body temperature and magnetosome T.sub.m for stable circulation and magneto-thermally triggered release. We therefore strived to further refine the vesicle assembly of DPPC by investigating the action of chemical inhibitors of interdigitation such as cholesterol, trehalose or DMSO. Admixture of cholesterol at 20% n/n readily gave rise to monomodal size distributions centered at 100 nm (FIG. S-4). Yet cholesterol is known to fill up voids in the bilayer and thereby strongly reduce the co-encapsulation of hydrophobic agents such as our SPIONs. Trehalose (1.5M) yielded a bimodal size distribution of SUVs and a broad distribution of LUVs (
[0175] Addition of 20% v/v DMSO below Tm also resulted in a bimodal size distribution (
Example 8: Comparison of Nanoparticle Loading Methods
[0176] Previously, rehydration of SPIONs together with lipids from a dried film followed by extrusion has been used to load SPIONs into membranes of small to large unilamellar vesicles (Amstad et al., Nano Lett., 2011, 11, 1664-1670; WO 2011/147926). This benchmark was compared to the solvent inversion method for 3.5 nm in diameter Fe.sub.3O.sub.4 nanoparticles coated with N-palmityl-6-nitrodopamine at a grafting density of 2.7/nm.sup.2. The DLS data is summarized in
[0177] Pure rehydration gave rise to broad, polydisperse size distributions with a time-dependent loading content of embedded nanoparticles. SPIONs precipitated over time, which led to a decrease in particle content with time. OD measurements showed that a minimal amount of SPIONs was retained after overnight suspension at room temperature (see
[0178] Subsequent extrusion of rehydrated dispersions through polycarbonate membranes reconfirmed previous observations of significant loss of lipid and nanoparticle material. An almost colorless suspension is obtained, for which the embedding of SPION was pushed below the UV/VIS detection limit (
[0179] Solvent inversion to 0.5 mg/ml of final lipid concentration yielded markedly colored, clear suspensions with an OD at 350 nm corresponding to the calibrated extinction of 5% w/w addition of SPION (cf.
Example 9: Determination of Loading Content
[0180] The influence of the nanoparticle mass fraction on SPION loading and vesicle morphology was investigated at a fixed lipid concentration of 0.5 mg/ml. The SPION concentration was varied from 1 to 20% w/w and prepared by solvent inversion. The lipid-nanoparticle mixture was dissolved in 1 ml THF and added dropwise into 10 ml of Milli-Q water under magnetic stirring at room-temperature. THF was evaporated for 12 h in an open vial under constant magnetic stirring in a well-ventilated area. The as-prepared magnetoliposome suspensions were stable for >3 weeks in plastic cuvettes at both 4 C. and RT.
[0181]
[0182] The amount of incorporated SPIONs was cross-evaluated by thermogravimetric analysis (TGA) and resulted in close agreement with the results obtained by UV/VIS (
[0183] Representative TEM images of the 5% w/w loaded vesicles fixed in 1% trehalose exhibit spherical morphology with a size distribution that agrees well with that obtained by DLS (
Example 10: Influence of Residual Oleic Acid from SPION Synthesis on Assembly Behavior
[0184] The size distributions of the SPION-lipid assemblies prepared by solvent inversion were significantly influenced by the purity of the SPIONs. The presence of residual impurities was confirmed for magnetoliposome preparations with incompletely purified SPION samples by recording ATR-FTIR spectra of the lyophilized preparations. Freely associated or physisorbed oleic acid shows up for samples prepared with incompletely purified SPIONs at higher input concentrations as a shoulder at 1705 cm.sup.1 (
[0185] This polydispersity with different types of aggregates could explain the quantitatively different OD curves for standard and spectroscopically pure SPIONs, where for the latter only P-NDA could be identified on the particles by IR spectroscopy (
[0186] For spectroscopically pure SPIONs the resulting assemblies showed similar size distributions as for the unloaded case up to >20% w/w SPION input. The PDI for loaded and unloaded preparations were comparable at 0.2. In contrast we observed an upper loading limit for impure SPIONs at around 10% w/w (
[0187] Another striking difference was observed in relation to formation of magnetoliposomes in different buffers (
[0188] The demonstration of the strong influence of the partitioning of small amounts of residual oleic acid from the particles to the lipid membrane on the magnetoliposome assembly and stability underscores how important well-defined and characterized starting materials will be for production of, for example, triggered drug delivery liposomes. Accumulation and partitioning of amphiphilic solutes is determined by the molecular structure of the detergent and the phase state of the lipid membrane.
Example 11: Controlling Magnetoliposome Size
[0189] Low Concentration RegimeTHF:H.sub.2O Ratio
[0190] A variation of the inversion ratio between 1:5 to 1:20% v/v (THF:H.sub.2O) showed that the obtained size distribution of formed vesicles can be tuned by adjusting the solvent-to-water ratio for lipid concentrations below 1 mg/ml (
[0191] High Concentration RegimePost-Extrusion
[0192] Assemblies formed above a lipid concentration of a few mg/ml were characterized by poor control over size, lamellarity and long-term stability, but formation of concentrated vesicle samples is preferred for applications. Post-extrusion through 100 nm pore-size track-etched polycarbonate membranes after complete evaporation of the organic solvent resulted in unilamellar preparations of controlled size also at high lipid concentrations. Surprisingly this approach allowed producing magnetoliposomes with higher SPION content compared to rehydration and extrusion (
[0193] Influence of SPION Size on Assemblies
[0194] Differently sized SPIONs (3.5, 4.5 and 8.3 nm) were tested for loading into POPC vesicles by solvent inversion. The SPIONs of different sizes exhibit similar grafting densities but vastly different chain end densities at the outer particle surface due to the increasing free volume at the outer shell for higher particle curvature (decreasing size). This particle size dependent thinning of the ligand shell yields 3 nm SPIONs with light shells and large interaction volumes for surrounding solutes whereas 8 nm SPIONs show roughly three times higher shell density at the outer surface.
[0195] Solvent inversion with all SPION sizes yielded markedly colored suspensions without precipitation. DLS showed comparable size distributions with scattering maxima around 100 nm for all preparations (
[0196] Addition of 8.3 nm SPIONs to lipids via solvent inversion resulted in dispersed nanoparticles. However, a closer inspection in TEM of samples with 8.3 nm SPION showed exclusive nanoparticle localization in lipid droplets, i.e. SPION aggregates surrounded by a lipid (mono-)layer. These SPION-lipid droplets co-exist with unloaded vesicles (
[0197] To investigate the fraction of particle aggregates we employed absorption spectroscopy before and after magnetic chromatography of the samples on a magnetic column. UV/VIS was used to assess the amount of aggregates formed (
[0198] Samples prepared with 8.3 nm SPIONs lead to almost complete removal of SPIONs during magnetic chromatography even at 5% w/w input (
Example 12: Magnetosome Stability
[0199] Magnetoliposomes (5% w/w 3.5 nm SPION with POPC lipids) were stored in PMMA cuvettes at room temperature and at 4 C. under ambient atmosphere. Sample integrity was confirmed at various time intervals using DLS and found to be preserved for at least one month (
Example 13: Polymer Synthesis
[0200] Polyisoprene macroRAFT Agent (1): HOOC-PI(1300)-DTB
[0201] Polyisoprene macroRAFT agent (1) was prepared as in reference with slight modifications. RAFT agent (81 mg, 0.29 mmol) and AIBN (24 mg, 0.146 mmol) were weighed into a thick walled glass tube. N.sub.2-saturated anhydrousTHF (5.5 mL) and isoprene (6 mL, 59.9 mmol) were added and the resulting mixture was sealed under inert atmosphere. The glass tube was placed in a preheated oil bath (T=125 C.) and polymerized for 2 h. The tube was then allowed to cool down to room temperature the content was concentrated in vacuo. The resulting red-pinkish viscous oil was taken up in minimal DCM and precipitated in methanol. Compound (1) was collected by centrifugation (5000 rpm/10 min/rt), washed with methanol and dried in vacuo. Yield: 225 mg (5.5%). The macro RAFT agent was dissolved in N.sub.2-saturated, anhydrous dioxane at a concentration of 75 mg/mL and stored at 20 C. until further use.
[0202] .sup.1H-NMR (300 MHz, CDCl.sub.3, ): 7.98 (d, 2H, J=7.5 Hz, Ph), 7.51 (t, 1H, J=7.3 Hz, Ph), 7.37 (t, 2H, J=7.4 Hz, Ph), 5.76 (1H, 1,2-PI), 5.12 (1H, 1,4-PI), 4.90 (2H, 1,2-PI), 4.69 (2H, 3,4 PI), 4.01 (t, 2H, J=7.9 Hz, CH.sub.2SC(S)), 1.5-2.3 (CH.sub.2, CH.sub.2 PI). UV/VIS (1,4-dioxane, .sub.abs, nm): 280 (Ph-), 296 (CS), 334 (sh), 500 (Ph(CS)S)
[0203] The PI-block of the macro-RAFT agent displayed the following microstructure: 90% 1,4-addition (cis/trans2/1), 5% (1,2-addition) and 5% (3,4-addition).
[0204] Polymerization of N-Isopropylacrylamide ([M]/[macroRAFT Agent]: 167/1): HOOC-PI(1300)-b-PNIPAM(1000)-DTB
[0205] The thermoresponsive PNIPAM blocks were prepared similar to Shan et al. (Macromolecules 2009, 42, 2696.). Macro-RAFT agent 1 (1.33 mL, 75 mg/ml) was added to a solution of NIPAM (1.52 g, 13.4 mmol) and AIBN (0.82 mg, 0.005 mmol) in anhydrous dioxane (6.4 mL). After purging the solution with nitrogen for 20 min, the flask was immersed into a preheated oil bath (70 C.) for 20 h. After cooling down, the flask was attached to a high vacuum system to remove dioxane and sublimate residual monomer. The crude residue was washed with hot water several times and subsequently freeze-dried.
[0206] RAFT Head Group Removal: HOOC-PI(1300)-b-PNIPAM(1000)-SSMe (2)
[0207] Cleavage of the DTB headgroup was conducted according to a modified procedure of Roth et al. (Macromolecules 2008, 41, 8316.). The light orange polymer was dissolved in anhydrous THF (4 mL) and mixed with S-methyl methanethiosulfonate (188 L, 2.25 mmol). After purging the resulting solution with nitrogen, (2-dimethylamino) ethylamine was dropwise added via a syringe (110 L, 1 mmol). Discoloration to a faint-yellow solution is indicative of dithioester removal and was observed within 3 h. To assure complete conversion, the reaction was allowed to stir overnight. The solution was concentrated and the residue was washed with water and methanol. After drying, the crude product was purified via silica gel column chromatography. First, residual polyisoprene was eluted using DCM/MeOH 100/1, then block copolymer 2 was obtained using DCM/MeOH 6/1 as eluent. Yield: 38 mg (21%).
[0208] .sup.1H-NMR (300 MHz, CDCl.sub.3, ): 6.90 (1H, NH, PNIPAM), 5.76 (1H, 1,2-PI), 5.12 (1H, 1,4-PI), 4.90 (2H, 1,2-PI), 4.69 (2H, 3,4-PI), 4.00 (1H, s, CH(CH.sub.3).sub.2 PNIPAM), 0.8-2.2 (CH.sub.2, CH.sub.3 PI, CH.sub.2, CH, PNIPAM), calculated from the M.sub.n (MALDI-TOF MS) the block copolymer composition is PI.sub.17-b-PNIPAM.sub.8.5
[0209] .sup.13C-NMR (75 MHz, CDCl.sub.3, ): 174.6 (CO, PNIPAM), 135.1 (1,4 CC, PI), 125.0 (1,4 CC, cis, PI), 124.2 (1,4 CC, trans, PI), 111.2 (1,2 and 3,4 CC, PI), 41.6 (CHCO, PNIPAM), 39.8 (CH.sub.2, PI), 38.5 (CH.sub.2, PNIPAM), 32.0 (CH.sub.2, PI), 29.7 (CH.sub.2, PI), 28.3 (PNIPAM), 26.7 (CH.sub.2, PI), 23.5 (CH.sub.3, PNIPAM), 22.5 (CH.sub.3, 1,4-cis, PI), 16.0 (CH.sub.3, 1,4-trans, PI).
[0210] MALDI-TOF MS (DHB, no salt added) M.sub.n: 2337 g/mol, polydispersity: 1.14. For [M]/[Macro RAFT agent]: 167/1 a BCP with 40 vol-% PNIPAM was obtained.
[0211] ATR-FTIR (powder, cm.sup.1): 3600-3200 (b, OH), 3300 (NH, amA), 3070 (CH.sub.2, 3,4-PI), 2966 (CH.sub.3), 2924 (CH.sub.2), 2874 (CH.sub.3), 2854 (CH.sub.2), 2234 (CN), 1715 ((CO)OH), 1642 (CO, amI+CC, 3,4 & 1,2 PI), 1540 (NH, amII), 1453 (CH.sub.3, PNIPAM), 1383 (CH.sub.3, t-1,4-trans PI+PNIPAM), 1368 (CH.sub.3, PNIPAM), 1264 (NH, amIII), 1172, 1130 (CC, c-1,4-cis PI), 1098, 1027 (CCH.sub.3, c-1,4-cis PI), 1004 (CC, 3,4-PI), 909 (CH.sub.2, 1,2-PI), 886 (CH.sub.2, 3,4-PI), 840 (CHCH, c,t-1,4-cis,trans PI), 690 (NH, amV), 510
[0212] UV/VIS (MeCN, .sub.abs, nm): 208 (CONH), 272 (sh, SSMe))
Example 14: Polymer Vesicle Formation and Release Study
[0213] Solvent Inversion:
[0214] Magnetic polymersomes were prepared by self-assembly of the amphiphilic block copolymer poly(isoprene-b-N-isopropylacrylamide) (PNIPAM) with monodisperse hydrophobic superparamagnetic iron oxide nanoparticles (SPION). A PI-b-PNIPAM block copolymer (BCP 2) with thermoresponsive volume fractions of 40% v/v was prepared by sequential RAFT polymerization. Multilamellar vesicles (MLVs) were formed by a protocol modified from Dorn et al. (Macromol. Biosci. 2011, 11, 514). Typically, 4 mg block copolymer were mixed with the respective weight percentage of hydrophobic SPIONs and dissolved in 200 l THF. The mixture was dropwise added into 2 ml aqueous medium (buffer or ultrapure water) containing 5 mg/ml calcein (0.2 m filtered) under magnetic stirring. The solvent was evaporated at room-temperature under a constant N.sub.2 stream for 3 h and while adding Milli-Q to keep the original total volume. The as-prepared vesicle suspension was extruded 10-times through 100 nm track-etched polycarbonate membranes in a hand-held extruder (Avanti) to increase the encapsulation efficiency and improve lamellarity.
[0215] Release Assays:
[0216] Removal of nonencapsulated dye and free nanoparticles from the extruded samples was performed on a Bio Logic Duo Flow chromatography system equipped with a UV-detector, a Knauer Smartline RI 2300 detector and a Bio Logic BioFrac collector. In detail, the samples (2 mL, 2 mg/ml) were purified by passing over a FPLC-column (lengthdiameter: 60 cm3 cm, stationary phase: Superdex 75) in Milli-Q water with a flow rate of 0.75 mL/min. Fractions of 2 mL containing the desired sample (usually 4 fractions) were identified by UV and RI detection. The sample concentration decreased to 0.5 mg/mL by the purification process.
[0217] Magnetic Actuation:
[0218] The as-prepared sample was filled in a PMMA cuvette which was placed in an Ambrell Easy Heat LI magnetic heater, with a current of 438.9 A and a frequency of 228 kHz, coil dimension (heightouter diametercoil thicknessnumber of turns=37 mm37 mm2 mm6). Magnetic actuation was performed in 8 or 10 min cycles, with a delay of 5 min between the cycles for recording of the released amount of calcein via fluorescence spectroscopy.
[0219] Fluorescence Measurements:
[0220] Fluorescence spectra were collected with a PerkinElmer LS 55 luminescence spectrometer at an excitation wavelength of 495 nm and an emission wavelength of 515 nm with a scan speed of 100 nm/min and a slit width of 2.5 nm. In some cases, the sample was diluted further in order to be within the optimal working range of the photo detector. Release of calcein was calculated according to the formula
where I.sub.i is the initial fluorescence intensity measured immediately after column purification, I.sub.AMF is the fluorescence intensity measured after the sample was subjected to individual AMF treatments and I.sub.PL is the fluorescence intensity measured at different times without applying any AMF in order to calculate passive leakage. I.sub.tot is the total fluorescence intensity measured after complete lysis of the vesicles by addition of Triton X100 (10% v/v of 20% Triton in MQ water).
Example 15: Determination of the Iron Oxide Nanoparticle Loading
[0221] For TGA determination of the effective SPION content of the polymersome membranes the lyophilized samples were burnt under oxidative conditions (synthetic air) to yield near complete combustion. Yet a considerable residue (11% w/w) remained even in the case of polymersomes containing no SPIONs. The reported final SPION loading content therefore refers to the non-combusted material at 650 C. in excess of the residue for samples not containing nanoparticles, which amounts to approximately 9% w/w for extruded SPION loaded samples.
[0222] Optical density (OD) values at 350 nm (OD.sup.350) were used for spectroscopic quantification of the SPION embedding efficiency. The OD.sup.350 values were obtained by dilution of the respective suspensions to match the amide absorptions at 208 nm. Background spectra of the plain extruded PI-b-PNIPAM vesicles were recorded to account for vesicular scattering. The OD.sup.350 value of the initial SPION loaded suspension was assigned to the input SPION weight fraction (20%) and the final loading content was determined by evaluating the OD.sup.350 decrease upon extrusion. In this way we estimate an effective loading content of around 9% w/w which is similar to the one obtained by TGA.
Example 16: Comparison of Polymeric Vesicles
[0223] Vesicle formation of SPION-loaded BCP 2 depended on experimental conditions such as preparation method, temperature, aqueous phase composition and additional energy input (e.g. sonication). Initial attempts to produce loaded vesicles via standard rehydration in Milli-Q/calcein (5 mg/ml; 0.2 m filtered) or phosphate buffered saline (1PBS; 10 mM NaHPO.sub.4/150 mM NaCl)/calcein solution required improvement because of minimal dispersion of the nanoparticle/BCP 2 film into those phases at ambient conditions. Neither gentle temperature variations nor sonication improved on vesicle formation.
[0224] Vesicles of BCP 2 (M.sub.n2300 g/mol, D=1.14, (PNIPAM)=40% v/v) were instead prepared at 1 mg/mL by solvent inversion into ultrapure water and calcein.
[0225] Dynamic light scattering (DLS) showed structures with a broad distribution of hydrodynamic sizes of 0.1-1 m for the turbid as-prepared suspension (
[0226] Multilamellar large vesicles are of limited use for release applications. Standard methods to enforce unilamellarity and decrease vesicle size are sonication and extrusion. Sonication at constant T=20 C. led to polymer and nanoparticle precipitation. Extrusion through track-etched polycarbonate membranes caused loss of hydrophobic SPIONs and some polymer but did not lead to precipitation. The measured DLS curves and OD.sup.350 values (
[0227] DLS size distributions (15966 nm) and TEM of extruded SPION-loaded vesicles with encapsulated calcein are shown in
[0228] The fluorescent dye calcein was encapsulated at self-quenching concentrations. Samples were purified from excess dye by size exclusion chromatography over a Superdex 75 FPLC column in ultrapure water and fractionated according to UV absorption and refractive index. The purification reduced the sample concentration to 0.5 mg/mL.
[0229] Release of encapsulated calcein to the bulk phase was quantified by recording the increase in fluorescence intensity as function of time and membrane actuation. The change in fluorescence intensity was obtained after subtraction of background fluorescence and normalizing to the total fluorescence after disruption of the vesicles by Triton. Magneto-thermal release was triggered by applying an alternating magnetic field (AMF) of variable duration and intensity. The resulting relative increase in fluorescence was compared to the passive release in absence of an applied field. The fluorescence resulting from triggered release of calcein from PI-b-PNIPAM polymersomes with 3.5 nm SPIONs incorporated in the membrane is shown in
[0230]
[0231] The PI-b-PNIPAM polymersomes showed reversible decrease in hydrodynamic size upon increased temperature rather than disintegration of the whole vesicles. This behavior was independent of the upper temperature (35 C., 45 C. or 55 C.). Also for extruded vesicles no significant change in scattering intensity or size was observed after reversible heating (
Example 17: Manufacture of Fluorescent Hybrid Polymersome Vesicle
[0232] Reagents and Materials
[0233] Meldrum's acid (2,2-Dimethyl-1,3-dioxane-4,6-dione) 98%; 4-(Diethylamino)salicylaldehyde 98%; Piperidine ReagentPlus 99%; Glacial acetic acid ACS reagent >99.7%; %; 1,4-Diazabicyclo[2.2.2]octane ReagentPlus 99%; Succinic anhydride >99% (GC); Dicyclohexylcarbodiimide puriss 99% (GC); 4-(Dimethylamino)pyridine ReagentPlus 99; N,N-Diisopropylethylamine ReagentPlus 99%; N,N-Diethyldiethylenetriamine 98%;
[0234] Phosphate buffered saline tablets (0.01 M phosphate buffer, 0.0027 M potassium chloride and 0.137 M sodium chloride, pH 7.4), Milli-Q water (Millipore USA; R=18 Mcm); Ethanol anhydrous 99.8%; Acetone Chromasolv Plus for HPLC 99.9%; Dichloromethane anhydrous 99.8% (contains 40-150 ppm amylene as stabilizer); Tetrahydrofuran Chromasolv Plus for HPLC 99.9% (inhibitor-free);
[0235] Polybutadiene(1200)-block-polyethyleneoxide(600) was obtained from Polymer Source Inc. 1,2-dioleoyl-sn-glycero-3-ethylphosphocholine chloride salt (DOPC.sup.+) was obtained from Avanti Lipids Inc. Branched poly(ethylene imine) (<M.sub.w>800 g/mol by LS, <M.sub.n>600 g/mol by GPC) was purchased from Sigma Aldrich.
[0236] TEM and Analysis:
[0237] TEM studies were performed on a FEI Tecnai G2 20 transmission electron microscope operating at 160 kV. Samples were prepared by loading freshly cut ultrathin-sections onto 300-mesh carbon-coated copper grids and subsequently air drying them overnight.
[0238] Confocal Microscopy:
[0239] All images were recorded on a Leica SP5 II Laser Scanning Confocal Microscope equipped with LCS software and a HCX APO L 40/0.80 objective. Samples were excited at 405 nm (cw, 50 mW) and their emission was collected. Samples were imaged in transmission mode by placing one drop of the cell culture onto glass cover slips or into plastic wells mounted onto glass cover slips (manufacturer). The temperature of microscope stage was controlled with warmed platforms (manufacturer). All spectra were corrected for autofluorescence of the cells.
[0240] Dynamic Light Scattering:
[0241] Hydrodynamic diameters and Zeta potentials were recorded on a Malvern Zetasizer Nano-ZS (Malvern UK) in PBS (1; 10 mM NaHPO4, 2.7 mM KCl, 137 mM NaCl, pH=7.4) at 25 C. in 173 backscattering mode. Samples were equilibrated for 120 sec. each and the autocorrelation function was obtained by averaging 3 runs. Samples were measured at 100 g/ml.
[0242] .sup.1H-NMR Measurements:
[0243] .sup.1H-solution spectra were collected on a Bruker DPX spectrometer operating at 300 MHz. Chemical shifts were recorded in ppm and referenced to residual protonated solvent (CDCl.sub.3: 7.26 ppm (.sup.1H).
[0244] ESI-MS Measurements:
[0245] Mass spectra were collected using a Q-Tof Ultima ESI (Waters, USA) mass spectrometer in positive ion mode (range 100-1500 Da). Samples were dissolved in MeOH and diluted to 100 g/ml.
[0246] ATR-FTIR Measurements:
[0247] Mid-IR powder spectra of the lyophilized samples were collected using a Bruker Tensor 37 FTIR spectrometer with a Bruker Platinum Diamond single reflection ATR equipment at a resolution of 4 cm.sup.1 by averaging 32 scans.
[0248] UV-Vis Measurements:
[0249] UV-Vis absorption spectra were collected at a scan speed of 400 nm/min on a Hitachi UV-2900 spectrophotometer.
[0250] Fluorescence Measurements:
[0251] Fluorescence spectra were collected with a PerkinElmer LS 55 luminescence spectrometer with a scan speed of 400 nm/min and a slit width of 2.5 nm.
[0252] TGA/DSC Measurements:
[0253] Thermograms were recorded on a Mettler-Toledo TGA/DSC 1 STAR System in the temperature range 25-650 C. with a ramp of 10K/min under 80 mL/min synthetic air gas flow. The mass loss was evaluated by horizontal step setting.
Synthesis of N-Palmityl-6-Nitrodopamide Capped Superparamagnetic Iron Oxide Nanoparticles (P-NDA SPIONs)
[0254] Monodisperse 5 nm P-NDA capped SPIONs were prepared as above. In a typical preparation 1 ml of iron pentacarbonyl (Fe(CO).sub.5) was quickly injected at 100 C. into a N.sub.2-saturated solution of 50 ml dioctylether (Oct.sub.2O) containing different amounts of oleic acid (OA), e.g. 4 ml OA for 5 nm SPIONs. An equilibration period of 30 min was employed to ensure homogenous formation of iron-oleate complexes. The solution was then gradually heated to 290 C. with a ramp of 3K/min. The final temperature was held for 1 h to obtain the desired particle sizes.
[0255] The as-synthesized magnetite nanoparticles were subsequently cooled to room-temperature, precipitated in excess EtOH, collected by magnetic separation and purified by repeated precipitation (toluene into EtOH)/magnetic decantation steps.
[0256] For irreversible grafting with N-palmityl-6-nitrodopamide 200 mg of as-synthesized OA-NP were purified from excess physisorbed OA by repeated sonication with 50 mg of Cetyltrimethylammoniumbromid (CTAB) in hot EtOH. SPIONs were collected by magnetic separation and residual CTAB was extracted with EtOH.
[0257] The purified OA-capped particles were taken up in 6 ml CHCl.sub.3 and mixed with 50 mg P-NDA dissolved in 3 ml DMF and 9 ml of MeOH. The SPION-ligand mixture was sonicated for 3 h under N.sub.2. CHCl.sub.3 was evaporated from the coating mix and the mixed-dispersant SPIONs were collected by magnetic precipitation from excess MeOH (40 ml) and purified by three rounds of washing and magnetic separation from hot MeOH (20 ml each).
[0258] Purified mixed-dispersant SPIONs were subjected to a post-coating step with 100 mg P-NDA in 2,6-lutidine at 50 C. for 48 h under inert atmosphere and magnetic stirring. Lutidine was evaporated, the particles were washed three times with excess hot MeOH and lyophilized from THF:Milli-Q (1:5).
[0259] ATR-FTIR (cm.sup.1): 3600-3000 (b; CONH, OH), 2955 (CH.sub.3), 2921 (CH.sub.2), 2851 (CH.sub.2), 1632 (CONH), 1546 (CONH), 1492 (CC, NO.sub.2), 1468 (CH.sub.2), 1437 (CC), 1374 (CH.sub.2), 1320 (NO.sub.2), 1276 (CC, CO), 1226, 1186, 1117, 1098, 1048 (CO), 880 (PhH), 814 (PhH), 571 (Fe.sub.3O.sub.4), 385 (Fe.sub.3O.sub.4)
[0260] TGA (O.sub.2, % w/w): 32; .sup.graft=2.8/nm.sup.2
Synthesis of 7-(Diethylamino)-Coumarin-3-Carboxylic Acid (DEAC-CA)
[0261] ##STR00001##
[0262] DEAC-CA was prepared by Knoevenagel condensation of para-substituted ortho-hydroxybenzaldehyde with alpha-CH acidic Meldrum's acid. Piperidinium acetate (PipHOAc) was prepared by dissolving 1 eq of piperidine in acetone and dropwise adding 1 eq. of glacial acetic acid under constant stirring. The white precipitate formed was collected by evaporation of the solvent and dried in vacuo.
[0263] A mixture of 4-(diethylamino)salicylaldehyde (20 mmol), Meldrum's acid (2,2-dimethyl-1,3-dioxane-4,6-dione; 2.89 g, 20 mmol), piperidinium acetate (58 mg, 0.4 mmol) and ethanol (10 mL) was stirred at room temperature for 30 min and refluxed for 3 h. The reaction mixture was allowed to cool down to room temperature, followed by chilling in an ice bath for 1 h. The product was filtered, washed three times with and recrystallized from EtOH. DEAC-CA was obtained as bright orange crystals in 80% yield.
[0264] .sup.1H-NMR (CDCl.sub.3, 300 MHz, ppm): 8.65 (s, 1H, Ph-CHC), 7.46 (d, 1H, Ph), 6.72 (dd, 1H, Ph), 6.54 (d, 1H, Ph), 3.50 (q, 4H, CH.sub.2), 1.26 (t, 6H, CH.sub.3)
[0265] ESI-MS (MeOH, m/z): [M]H.sup.+=262.11, cal c. 262.10; [M]Na.sup.+=284.10, calc. 284.08
[0266] UV/VIS (MeOH, nm): 217, 259 sh, 423
[0267] fluor (MeOH, nm): 482 (.sub.exc=420)
Synthesis of Poly(butadiene(1200)-block-ethyleneoxide(600))-O-(7-(Diethylamino)-coumarin-3-carboxylic ester) (PBD-b-PEO-DEAC)
[0268] ##STR00002##
[0269] 100 mg PBD-b-PEO were dissolved in 10 ml N.sub.2-saturated, anhydrous CH.sub.2Cl.sub.2 (DCM) under sonication and subsequently activated for 15 min with 1 eq. of 1,4-Diazabicyclo[2.2.2]octane (DABCO). Next 1.5 eq. DEAC-CA and 0.2 eq. 4-Dimethylaminopyridine (DMAP) were added and the 10% polymer solution was purged with N.sub.2 gas for 15 min before cooling to 0 C. in an ice-bath. N,N-Dicylcohexylcarbodiimide (DCC, 1.7 eq) in 5 ml DCM was dropwise added to the magnetically stirred polymer solution at 0 C. The reaction mixture was allowed to slowly warm to room-temperature and reacted in the dark for 3 days under inert atmosphere. The crude reaction mix was diluted with DCM, extracted thrice with 1M HCl, 5% NaHCO.sub.3 and washed with Milli-Q water. The combined organic phases were dried over Na.sub.2SO.sub.4, reduced in volume to approx. 5 ml and cooled to 20 C. Precipitated DCU was filtered off and the cooling-filtration procedure repeated. The organic phase was evaporated to dryness, taken up in CHCl.sub.3, loaded onto a SiO.sub.2-column (Silica 60) and washed with several volumes of MeCN to remove excess dye and by-products. The fluorescently labeled target compound was finally eluted in THF:MeOH=4:1. Lyophilization from THF:Milli-Q (1:10) yielded PBD-b-PEO-DEAC as a yellow viscous residue (dye content 5%).
[0270] .sup.1H-NMR (CDCl.sub.3, 300 MHz, ppm):
[0271] ATR-FTIR (powder, cm.sup.1): 3074, 2913, 2890, 1826, 1735, 1640, 1622, 1589, 1514, 1452, 1418, 1343, 1280, 1241, 1143, 1107, 1061, 993, 963, 907, 842, 673, 528
[0272] UV/VIS (MeOH, nm): 223, 259 sh, 420
[0273] fluor (MeOH, nm): 474 (.sub.exc=420)
Synthesis of Polybutadiene(1200)-block-Polyethyleneoxide(600)carboxylic acid (PBD-b-PEO-COOH)
[0274] ##STR00003##
[0275] 100 mg PBD-b-PEO were dissolved in 10 ml CH.sub.2Cl.sub.2 (DCM) under sonication and activated with 2 eq. of N,N-Diisopropylethylamine (DIPEA) for 15 min. 0.2 eq 4-Dimethylaminopyridine (DMAP) and 3 eq succinic anhydride (SucO) in 2 ml DCM were dropwise added to the above solution and purged with N.sub.2 for 10 min. The reaction mixture was refluxed overnight under inert atmosphere.
[0276] The crude product was diluted with DCM, extracted thrice with 1M HCl, 5% NaHCO.sub.3, washed with Milli-Q and brine. The organic phases were dried over Na.sub.2SO.sub.4, evaporated and dried in high vacuum overnight to yield 95% of a transparent viscous residue.
[0277] .sup.1H-NMR (CDCl.sub.3, 300 MHz, ppm):
[0278] ATR-FTIR (powder, cm.sup.1): 3680-3350 (b) 3074, 2913, 2890, 1826, 1735, 1640, 1447, 1418, 1349, 1330, 1300, 1249, 1101, 1039, 993, 951, 907, 860, 774, 675, 522
Synthesis of Polybutadiene(1200)-block-Polyethyleneoxide(600)-N {2-[[2-(Diethylamino)ethyl]amino]ethaneamide} (PBD-b-PEO-DEDETA)
[0279] ##STR00004##
100 mg PBD-b-PEO-COOH were dissolved in 15 ml N-Methyl-2-pyrrolidone (NMP) under sonication and activated for 15 min at room temperature with 1.1 eq. (1-Cyano-2-ethoxy-2-oxoethylidenaminooxy)-dimethylamino-morpholino-carbenium hexafluorophosphate (COMU) and 2 eq of N,N-Diisopropylethylamine (DIPEA). The activated acid was dropwise added to a solution of 5 eq. N,N-diethyldiethylenetriamine (DEDETA) in 10 ml NMP at 4 C., slowly warmed to room temperature and reacted overnight under inert atmosphere.
[0280] The crude product was diluted with DCM, extracted thrice with 1M HCl, 5% NaHCO.sub.3 and washed with Milli-Q and brine. The organic phases were pre-dried over Na.sub.2SO.sub.4, evaporated and dried in high vacuum overnight to yield 95% of a transparent to off-white viscous residue.
[0281] .sup.1H-NMR (CDCl.sub.3, 300 MHz, ppm):
[0282] ATR-FTIR (powder, cm.sup.1): 3630-3150 (b;) 3074, 2913, 2890, 1826, 1735, 1665, 1640, 1540, 1447, 1418, 1378, 1349, 1330, 1300, 1249, 1219 (solv), 1101, 1039, 993, 951, 907, 860, 774 (solv), 675, 563, 522
Example 18: Preparation Polymeric Magnetosomes by Solvent Inversion
[0283] Large unilamellar vesicles (LUVs) were formed as above with modifications. Typically 4 mg block co-polymers were mixed with the respective weight percentage of hydrophobic SPIONs and dissolved in 200 l THF. The mixture was dropwise added into 2 ml aqueous medium (buffer or ultrapure water) under magnetic stirring. The solvent was evaporated at room-temperature under a constant N.sub.2 stream for 3 h and continuously refilled with Milli-Q to its initial level. To remove non-encapsulated nanoparticles and improve lamellarity, the as-prepared vesicle suspension was homogenized by extrusion through 100 nm track-etched polycarbonate membranes (10-times) in a hand-held extruder (Avanti).
[0284] DLS size distributions of various nanoparticle-diblock copolymer assemblies are shown in
Example 19: Fluorescent Labeling
[0285] Fluorescent polymersomes were created by employing the small, hydrophobic dye (7-diethylamino coumarin)-3-carboxyic acid (DEAC-CA). DEAC-CA adds a fluorescent modification to the amphiphilic diblock copolymer poly(butadiene-b-ethylene oxide) (PBD-b-PEO) without perturbing the block-copolymer physicochemical properties. Its small size importantly avoids morphological changes of the assemblies caused by the addition of a fluorescent group. Furthermore, its hydrophobicity causes the dye to locate within the membrane interior rather than being presented at the interface, thereby avoiding undesired interactions with biomolecules. Conjugates of DEAC to PEG are known to be only mildly cytotoxic and possess high photoluminescence quantum yields (PLQY). Coumarins can also serve as reporters for ROSderived high energy species and changes in the local pH. Fluorescent modification of PBD-b-PEO polymersomes with DEAC-CA was achieved by Steglich esterification for 3 days in the dark giving 5% dye content. The rather modest yield is likely to originate from the deactivated character of the terminal acid group which is conjugated to the ring system. A dye content below 10% is however desired to avoid self-quenching effects.
[0286] We did not detect any appreciable change in Zeta potential upon conjugation of DEAC-CA to the PEO-headgroup of the diblock copolymer. This is expected for properly purified samples that do not contain excess free dye but a few percent of conjugated entities that are linked via neutral ester bonds. Luminescence spectroscopy on the dye-labeled polymersomes in water exhibited dye emission profiles that are indicative of a low polarity microenvironment. The Stokes shift and PLQY of the assembled DEAC-copolymer-conjugates in water resembles those of the free dye dissolved in a low dielectric solvent (THF) rather than when dispersed in an aqueous phase (Milli-Q water or buffer). We therefore conclude that the majority of the conjugated dye molecules are located within the hydrophobic membrane interior rather than being presented at the vesicle interface. A loss in the overall quantum yield however suggests an equilibrium fraction in contact with water since excited (dialkylamino)coumarins are efficiently quenched in protic, high dielectric solvents by population of twisted intramolecular charge transfer states.
[0287] The incorporation of SPIONs generally lead to a drastic decrease in fluorescence intensity but the signal is still easily distinguishable from the cellular autofluorescence background for an employed 10% w/w SPION loading. This is in strong agreement with the result of complete quenching of dyes linked directly by spacers to the SPION and our expectation of the DEAC being localized in the membrane interior. A high concentration of SPIONs in the membrane means that conjugated dyes will be quenched by the close proximity to the nanoparticle acceptor.
Example 20: Surface Modification of Polymeric Vesicles
[0288] Various surface modification approaches were tested for their potential to enhance the transfection efficiency of stealth polymersomes, with the aim of controlling delivery efficiency. We compare the efficiencies of surface adsorption of membrane-disruptive, low-Mw polymer to covalent modification of the scaffold diblock-copolymer with a short oligoamine sequence to a homogeneous supramolecular blend with cationic lipids (DOPC.sup.+) as enhancers to promote cell uptake Branched poly(ethylene imine) or b-PEI is a commonly used nonviral transfection agent comprising a combination of primary, secondary and ternary amines that strongly interact with negatively charged species such as DNA or native cell membranes. Its transfection efficiency can be tuned via the molecular weight and constituent structure. Both high Mw and branching of the polymer increase transfection efficiencies in-vitro. Adsorption of these membrane-disruptive agents to polymeric delivery vesicles was recently exploited as a means of transfection because their mechanical robustness allows for direct coating without breaking down the vesicle's membrane integrity as seen for lipid carriers. Moreover b-PEI is a prerequisite to ensure endosomal escape from lytic organelles which is essential for active compounds to reach their intracellular target. In contrast to artificial liposomes which are inherently sensitive to osmotic changes due to deficiency of proton-pumps, polymer vesicles require a drastic driving force for endosomal escape. An osmotic proton sponge effect is thought to be responsible for endosomal escape of b-PEI coated vesicles while their neutral precursors were shown to be stably trapped in acidic cell compartments without releasing their cargo. Neutral polymersomes require hydrolytic cleavage of the bilayer forming amphiphile to develop lytic properties through a change of the hydrophilic-hydrophobic balance. This approach however displays slow uptake kinetics when PEG is used as non-degradable hydrophilic block. In a first step we increased the affinity of b-PEI to the vesicle surface by carboxylation of the hydrophilic PEO-block via esterification with succinic anhydride prior to adsorption of b-PEI to the modified vesicles. Quantitative endgroup modification was verified by 1H-NMR and FTIR spectroscopy (see SI x). The resulting acid terminated polymer vesicles (40 mV) exhibited a clear shift in Zeta potential of 36 mV compared to the unmodified hydroxyl-functionalized diblock-copolymer assemblies (4 mV) in 0.1PBS. The carboxylic acid modification is therefore operational as electrostatic linker. Moreover, as a weak electrolyte the terminal acid maximally accounts for 1 negative charge per polymer-chain upon dissociation thus maintains a high + to ratio required for transfection and simultaneously minimizes polymersome membrane disruption by avoiding excessive electrostatic attraction among the modified scaffold diblock-copolymer and countercharged b-PEI. The abundant pH of 5-5.5 in early endosomes is close to the pKa of the acid group hence slight pH-responsiveness is imparted through dissociation of ionic cohesion in an acidic environment. A weakening of the attraction to the polycationic surface coating is thought to increase membrane disruptive and lytic effects of b-PEI to facilitate endosome disruption.
[0289] The efficiency of coating with low-Mw b-PEI(800) was markedly influenced by the procedure. While addition of 1 mol-equivalent of b-PEI to preformed PBD(1200)-b-PEO(600)-COOH vesicles only yielded a modest change in Zeta potential independent of adsorption time (1-24 h), input of 10 mol-excess drastically altered the surface charge. Subsequent syringe filtration through 0.2 m PVDF units however yielded negative Zeta potentials similar to those obtained for 1 eq. b-PEI (25 mV) while purification via size exclusion chromatography over Sephadex G-75 lead to charge neutralization (2 mV). This finding implies that low-Mw b-PEI polyelectrolyte might only be adsorbed in patches to the vesicle surface rather than being quantitatively associated as seen in the case of high-Mw analogues that readily invert surface charge.
[0290] Although the Zeta potentials of neutral PBD-b-PEO polymersomes and those of the PBD-b-PEO-COOH/b-PEI(800) samples were very close, confocal microscopy showed markedly improved transfection for the latter upon 24 h incubation with HeLa cells (see
[0291] Other tested alternatives for mild surface modification of the vesicles involved covalent attachment of oligoamine sequences to the hydrophilic COOH terminated block. Diethyldiethylenetriamine (DEDETA) units are often employed in context with cationic lipid transfection agents. Its conjugation to a scaffold polymer constitutes a lenient option to vesicles that do not directly expose a recognizable strongly cationic motif at the vesicle surface. The Mw of the DEDETA fragment is low thus it is not expected to trigger a significant volume transition that disintegrates the vesicle but to provide membrane disruptive potential upon charging in low pH compartments. Reaction conversion with DEDETA was 80% complete based on 1H-NMR (broad singlet at 8.21 ppm). Vesicles of PBD(1200)-b-PEO(600)-DEDETA depicted a Zeta potential of 6 mV as compared to 40 mV for the acid terminated precursor. As in the case of superficially adsorbed b-PEI(800) the surface charge could not be inverted but reset to around zero indicating either attenuation through co-existence of residual acid moieties and/or incomplete charging because of association of the oligoamine segments with the polymer occurs. Major differences in cellular fluorescence intensity despite similar Zeta potentials among b-PEI coated and DEDETA modified vesicles upon 24 h incubation with HeLa cells is indicative of that accessibility of the charged entities plays a significant role in determining the overall transfection efficiency. Similar findings on antigen presentation were reported for RGD modified polymersomes (e.g. PBD-b-PEO-RGD). DEDETA modified vesicles yielded fluorescence intensities that were comparable to slightly above those of unmodified vesicles, signaling ineffective transfection. B-PEI in contrast exhibited improved performance compared to unmodified and DEDTEA conjugated vesicles despite that all three displayed close to neutral Zeta potentials under identical conditions. Again this suggests that b-PEI is immediately amenable to cellular recognition while the covalantly bonded oligoamine segments are shielded by the hydrophilic corona or not strong enough to cause interactions with the outer leaflet of cellular membrane. The former explanation is favored considering that the conjugated groups are dissociated, which is expected for a conjugate in a well-solvated polymer such as PEG in water. This would also account for statistical positioning of the charged entities elsewhere than at the interface.
Example 21: Lipo-Polymeric Vesicles
[0292] An elegant approach that avoids the need for chemical surface modification of diblock copolymers and its purification is by blending the polymeric assembly with cationic lipids. This approach is not only thought to largely avoid neutrophil recognition by disguising the lipid antigen underneath a superficial PEG layer but also to promote vesicle fusion in a pH independent way as quaternary ammonium groups are endowed. The admixture of lipids further allows for tuning of the PEG density, hence for regulating recognition of the lipid antigen at the cell surface and eases endosomal escape through hydrolytic degradation of lipids leading to altered lysis characteristics.
Here we chose 1,2-dioleoyl-sn-glycero-3-ethylphosphocholine chloride salt (DOPC.sup.+) to achieve a homogeneous lipopolymersome blend. The incorporation of doubly unsaturated lipids was previously shown to give a uniform lipid distribution within PBD-b-PEO vesicles of moderate Mw. This homogeneity is further improved in our case by additional dispersion through charge repulsion among the cationic lipids. The measured Zeta potential of the blended sample was rendered overall cationic (+16 mV) in contrast to the above discussed modifications. Interestingly the polymer blend was considerable less cationic than for respective DOPC.sup.+ blended POPC liposome preparations (+50 mV). This strongly suggests that the cationic lipids are likely to be located close to the hydrophilic-hydrophobic interface of the block-copolymers and are thus shielded by a hydrated, neutral polymer layer while the charge is directly exposed at the interface for liposomes.
[0293] Cell uptake studies of cationic lipopolymersomes lead to highest transfection efficiencies observed as seen in
Example 22: Magneto(lipo)polymersomes
[0294] Monodisperse, irreversibly grafted superparamagnetic iron oxide nanoparticles (SPIONs) of maximal ligand density were prepared as above.
[0295] The obtained size distribution and overall lamellarity of the prepared sample however varies with aqueous phase composition and polymer concentration. At low amphiphile concentrations (<1 mg/ml) the formed polymersomes were predominately unilamellar while higher concentrated samples (>1 mg/ml) gave some multilamellar vesicles.
Example 23: Cell Uptake of Polymeric and Lipopolymeric Vesicles
[0296] Overnight incubation of human cervical adenocarcinoma cells (HeLa line) with differently prepared DEAC-labeled polymersomes gave rise to only a minor fluorescence signal within the cells in confocal microscopy. This indicates that unmodified PBD-b-PEO vesicles exhibit slow cellular uptake kinetics and significant stealth properties which is in line with earlier reports on uptake without irradiation.
[0297] Similar uptake behavior was observed among loaded vesicles prepared by solvent inversion or by rehydration plus extrusion despite different weight fractions of SPIONs incorporated in the membrane. This indicates that even at elevated SPION content, the non-fouling and stealth properties of the polymersomes are not compromised. In other words, either the adsorption of proteins to the polymersomes is not increased, that is, membrane embedded SPIONs do not act as sites for non-specific adsorption, or additionally adsorbed proteins remain well shielded by the PEO blocks. The former is the more plausible explanation and supported by that no associated proteins could be detected electrophoretically after incubation in cell culture media.
[0298] TEM confirmed modest uptake of unmodified mangetopolymersomes with a neutral, non-zwitterionic outermost PEG corona. Polymeric vesicles are easily identified in TEM by positive staining of the unsaturated PBD-block with OsO.sub.4. A rare event is shown in
[0299] Investigations on changes in the cellular ultrastructure after uptake of the supramolecular blend of diblock-copolymer with 30% n/n of the cationic lipid 1,2-dioleoyl-sn-glycero-3-ethylphosphocholine chloride salt (DOPC.sup.+) in the hybrid vesicle exhibited not only high uptake efficiency but also an increased amount of apoptotic cells. Ingested lipopolymersomes were of reduced lamellarity and resulted in more flexible structures than compared to plain polymersomes. A change in the elastic modulus of these hybrid systems was suggested previously and is supported by our findings. A high amount of intact vesicles in healthy cells is shown in
[0300] In contrast to polymersomes, hybrid lipopolymersomes were readily rendered cationic by incorporation of lipids and raised the intracellular iron content significantly. Co-localization studies showed that all surface-modified vesicles were preferentially located in lysosomes which is consistent with an endosomal uptake pathway. For cationic vesicles cellular ultrastructure showed an increased frequency of apoptotic features while neutral vesicles did not induce a conspicuous cellular stress response.
Example 24: Long-Term Stability and Release
[0301] The size and stability of the magnetoliposomes that were resized by sonication were investigated to ensure the formation of a monodisperse distribution of unilamellar liposomes.
[0302] The concentration of SPION in the membrane strongly affected the susceptibility of the liposomes to release encapsulated compounds triggered by exposure to alternating magnetic field.
[0303] It is important for the validity of the previous comparison as well as for applications that there is no passive release and that the phase transition can be reached without increasing the bulk temperature above T.sub.m. In the inset of
Example 25: Release from Nanoscale Unilamellar Hybrid Vesicles
[0304] The co-self-assembly behavior of the scaffold diblock copolymer PBD(1200)-b-PEO(600) with monodisperse hydrophobic ultra-small SPION was investigated. Assembling SPIONs at high density in the membrane without adversely affecting other desired properties for release applications such as unilamellarity and monodispersity is challenging. Accordingly, a method that allows for direct control over the spatial distribution and embedding efficiency of USPIONs as well as over vesicle size and lamellarity has to be found. We employed solvent inversion from THF into water (1:10), as it has been shown above. In brief, 0.5-1 mg of PBD(1200)-b-PEO(600) and the desired weight fraction of 3.5 nm N-palmityl-6-nitrodopamide capped ultra-small SPION (P-NDA-USPION) were dissolved in 100 l THF and dropwise added to a magnetically stirred solution of ultrapure water. The solvent was subsequently evaporated under a gentle stream of nitrogen gas for several hours.
[0305] To quantify magnetically triggered release, the fluorescent dye calcein was encapsulated at self-quenching concentrations in the aqueous lumen of the USPION-loaded vesicles with mixed membrane compositions. Magneto-thermal release was triggered by applying an alternating magnetic field (AMF) of variable duration and intensity. The resulting relative increase in fluorescence was compared to the passive release at room temperature in absence of an alternating magnetic field.
We employed monodisperse 3.5 nm in diameter N-palmityl-6-nitrodopamide capped magnetite nanoparticles with a grafting density of 2.7 molecules/nm.sup.2 (Bixner, 2015 supra and WO 2016/020524). Nanoscale, mixed amphiphile capsules were formed via solvent inversion (THF to calcein solution 1:10, 5 mg/ml calcein in Milli-Q water). All samples were sonicated for 30 min and subsequently extruded through 100 nm polycarbonate membranes in a hand-held extruder prior to release measurements to improve sample homogeneity. Release was measured on the monomodal, extruded suspensions, with an average diameter of 150 nm after size exclusion chromatography. An alternating magnetic field (f=228 kHz, B=94.7 mT) applied for different pulse lengths was used to investigate calcein release triggered by the release of heat from the USPION actuated magnetically at a frequency and field strength compatible with biological tissue.
[0306] The very stable vesicles of the non-thermoresponsive PBD(1200)-b-PEO(600) superamphiphile were little susceptible to magneto-thermal actuation. Only a negligible release of 10% in 3 h could be measured for 30% w/w USPION loaded PBD(1200)-b-PEO(600) vesicles when actuated even at extremely long magnetic pulse durations of 40 min (see
[0307] The released percentages of encapsulated calcein resulting from exposure of hybrid and blended magnetosomes with 3.5 nm USPIONs incorporated in the membrane to AMF pulses are shown in
[0308] The lipopolymersomes showed efficient release but with the high stability and low passive release of PBD(1200)-b-PEO(600) at a particle loading of 5% w/w that is higher than shown for liposomes. Higher particle loading increased passive release. At least half the loaded content could be efficiently released for lipopolymersomes. The remaining entrapped and possibly slowly releasing fraction was tentatively attributed to an inhomogeneous distribution of lipid among vesicles of different size during solvent inversion, which was suppressed by further optimization of the membrane composition or by using sonication as homogenization method.